FZE, a provider of AI-driven healthcare technology, announced a strategic agreement aimed at delivering Optima AI ...

Claritev Corp. Annual stock financials by MarketWatch. View the latest CTEV financial statements, income statements and financial ratios.

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On ...

Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and iO Health-FZE, ...

CLARITEV ($CTEV) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$3.43 per share, missing estimates of -$3.16 by $0.27. The ...

CTEV is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of CTEV shares has decreased $0.72 since the market last closed. This is a 1.05% ...

Claritev Corporation (NYSE:CTEV) is one of the must-buy small-cap stocks to invest in. On August 6, the company delivered its second-quarter results, asserting a return to growth bolstered by ...

DURHAM, N.C., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...

Claritev Corp. Annual cash flow by MarketWatch. View CTEV net cash flow, operating cash flow, operating expenses and cash dividends.

- Publication evaluated coronary tissue engineered vessel (CTEV) as a conduit for CABG in a nonhuman primate model - - All implanted CTEVs remained patent through six months, demonstrated adaptive ...